Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2003
08/28/2003WO2002041880A3 Use of pyrazolo[4,3-d]pyrimidines
08/28/2003WO2002000638A8 Substituted phthalides as anti-convulsive drugs
08/28/2003US20030162979 Substituted sulphonylamino(thio)carbonyl compounds
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162963 Novel expanded porphyrins and process for the synthesis thereof
08/28/2003US20030162960 Compounds containing pyrroles as the key recognition element and a quinoxaline backbone as part of the compound for use in system with a built-in optical probe for selective sensing
08/28/2003US20030162867 Stabilizer mixtures
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162801 Tricyclic compounds and their uses
08/28/2003US20030162800 Nitrogen compounds such as 10-Butyl-8-chloro-10-(trifluoro methyl)-5,10-dihydropyrimido(5,4-b)quinolin-4(3H)-one, used as polymerase inhibitors for prophylaxis of viral diseases
08/28/2003US20030162798 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
08/28/2003US20030162797 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/28/2003US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
08/28/2003US20030162782 Treating a patient suffering from neuropathy with sidenafil, free of 5-(3-pyridyl)pyrazoleo(4,3-d)pyrimidine-7-one, 2-(3-pyridyl)-4a,5-dihydroimidazo(5,1-f)(1,2,4)triazine-4(3H)-one or 2-phenylpurine-6-one, all are substituted
08/28/2003US20030162777 Administering a biheterocyclic compounds containing aminocarbonyl, aminothiocarbonyl or aminosulfonyl group for treating neuromuscular dysfunction of the lower urinary tract in a mammal in need of such treatment
08/28/2003US20030162766 Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162747 Administering otoprotectant glutathione peroxidase mimic (ebselen), xanthine oxidase inhibitor (allopurinol), and glutathione precursor (N-acetylcysteine)
08/28/2003US20030160212 Stacked mixtures; low temperature conductivity
08/28/2003CA2477117A1 Pyrrolopyrimidine derivative
08/28/2003CA2477116A1 Pyrrolopyrimidine derivatives
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476624A1 Azabicyclic compounds for the treatment of disease
08/28/2003CA2476417A1 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
08/28/2003CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/27/2003EP1338598A1 Process for the preparation of triethylenediamine (TEDA)
08/27/2003EP1338597A1 1,4,5,6-tetrahydroimidazo 4,5-d]diazepine derivatives or salts thereof
08/27/2003EP1338337A2 Catalysts and methods for catalytic oxidation
08/27/2003EP1337535A2 Benzodiazepine derivatives as gaba a receptor modulators
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337150A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
08/27/2003EP1165547B1 Substituted benzoylpyrazoles as herbicides
08/27/2003EP1140938B1 High affinity inhibitors for target validation and uses thereof
08/27/2003EP0920314B1 Non-peptide g-csf mimetics
08/27/2003EP0891363B1 Heterocyclic compounds and their preparation and use
08/27/2003EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials
08/27/2003EP0842157B1 Herbicidal sulphonylamino(thio)carbonyl compounds
08/27/2003CN1439011A 5-aminoalkyl-pyrazolo [4,3-d] pyrimidines with phosphodiesterase v-inhibiting effect
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439009A Imidazo pyrimidine derivatives and triazolopyrimidine derivatives
08/27/2003CN1439008A 1-(heteroaryl-henyl)-condensed pyrazol derivatives as factor XA inhibitors
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1439002A Muscarinic agonists
08/27/2003CN1439001A Tetrahydropyridino or piperidino hetlrocyclic derivatives
08/27/2003CN1438993A Ethylenediamine derivatives
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/26/2003US6610847 Tyrosine kinase inhibitors; immunosuppressants
08/26/2003US6610731 Antiinflammatory
08/26/2003US6610697 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods
08/26/2003US6610694 Condensed pyridazine compounds, their production and use
08/26/2003US6610688 For therapy of blood vessel proliferative disorders; fibrotic disorders; mesangial cell proliferative disorders; metabolic disorders; allergies; asthma; thrombosis; nervous system diseases; and cancer
08/26/2003US6610685 Fused indole derivatives
08/26/2003US6610684 Fused azepinone cyclin dependent kinase inhibitors
08/26/2003US6610677 Enhancing glycogen synthesis, lowering blood levels of glucose, treating colon, ovarian, or breast cancer, treating diabetes, treating schizophrenia
08/26/2003US6610483 Method for the identification of a pattern of changes in cellular responses induced by the selective inhibition of a signaling molecule, by determining the specific effects of a selective inhibitor on a mutant form of signaling molecule on
08/26/2003CA2092211C Imidazole compounds, their preparation and use
08/22/2003CA2418930A1 Use of agents that modulate pde11a activity
08/21/2003WO2003069303A2 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof
08/21/2003WO2003068866A1 Compounds, compositions and uses
08/21/2003WO2003068779A1 Cyclic compounds and their use as complex ligands
08/21/2003WO2003068777A1 Aluminium and hexamethylenetetramine complex and the applications thereof
08/21/2003WO2003068776A1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES
08/21/2003WO2003068775A1 Method for producing n-ethyl-n-[3-(3-cyanopyrazolo[1,5a]pyrimidine-7-yl)phenyl acetamide
08/21/2003WO2003068759A1 Piperazine derivatives as anti-inflammatory agents
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068237A1 Beta-sheet mimetics and composition and methods relating thereto
08/21/2003WO2003068220A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
08/21/2003WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003WO2003045906A3 Synthesis of 2-cyanoziridine-1-carboxamide
08/21/2003WO2003001887A3 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
08/21/2003US20030158405 N-benzhydryl indole compounds
08/21/2003US20030158224 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents
08/21/2003US20030158219 N-substituted spiropiperidine compounds as ligands for ORL-1 receptor
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158206 Sildenafil mesylate for the treatment of male erectile dysfunction or female sexual disorders.
08/21/2003US20030158203 Triazolo-pyridazine derivatives as ligands for GABA receptors
08/21/2003US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
08/21/2003US20030158197 Certain alkylene diamine-substituted heterocycles
08/21/2003US20030158190 6-phenyl-pyrazolopyrimidines
08/21/2003US20030158184 Treating male impotence, sexual disorders; donates, transfers or releases nitrogen monoxide
08/21/2003US20030158173 NK 1 antagonists
08/21/2003US20030157435 Use of a composition in stereolithography
08/21/2003US20030157191 Administering to a subject undergoing chemotherapy an amount of a chemoprotectant
08/21/2003US20030157107 Agents for preventing or ameliorating insulin resistance and/or obesity
08/21/2003CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003CA2476113A1 Beta-sheet mimetics and composition and methods relating thereto
08/21/2003CA2472822A1 Chemical compounds
08/20/2003EP1335988A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
08/20/2003EP1335921A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy
08/20/2003EP1335919A1 Novel compounds
08/20/2003EP1335918A1 Novel compounds
08/20/2003EP1335730A1 Treatment of premature ejaculation
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1212326A4 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
08/20/2003EP1173519B1 Novel carbopyronine fluorescence dyes
08/20/2003EP1165542B1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
08/20/2003EP1150944B1 N2-phenylamidine derivatives
08/20/2003EP1102770B1 Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical preparations containing same, method for producing same and their use in magnetic resonance imaging of necrosis and infarction
08/20/2003EP1090005B1 PYRAZOLO 1,5-a]TRIAZINE CORTICOTROPIN RELEASING FACTOR ANTAGONISTS
1 ... 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 ... 573